首页> 外文期刊>fetal diagnosis and therapy >Prenatal Diagnosis of Trisomy 21 in Monozygotic Twins with Increased Nuchal Translucency and Abnormal Serum Biochemistry
【24h】

Prenatal Diagnosis of Trisomy 21 in Monozygotic Twins with Increased Nuchal Translucency and Abnormal Serum Biochemistry

机译:Prenatal Diagnosis of Trisomy 21 in Monozygotic Twins with Increased Nuchal Translucency and Abnormal Serum Biochemistry

获取原文
       

摘要

We present a case of a monozygotic twin pregnancy who underwent routine screening for chromosomal abnormalities at 14 weeks of gestation by ultrasonographic measurement of nuchal translucency and biochemical analysis of maternal serum alpha fetoprotein and free beta human chorionic gonadotrophin levels. Both screening methods indicated the pregnancy to be at increased risk of Down syndrome, with the ultrasound findings suggesting both fetuses to be affected. An amniocentesis was performed, and karyotype analysis revealed trisomy 21 in both fetuses; the mother subsequently opted for a termination of pregnancy. This case illustrates that screening for trisomy 21 in twin pregnancies is possible by both nuchal translucency measurement and maternal serum markers.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号